The medical management of renal stone disease focuses not only on treating existing kidney stones but also on identifying and correcting factors responsible for recurrent stone formation. Patients with repeated kidney stones undergo detailed metabolic evaluation to assess abnormalities such as hypercalciuria, hyperoxaluria, uric acid disorders and other metabolic risk factors.

Based on the findings, personalised treatment may include dietary modification, optimisation of fluid intake, correction of metabolic abnormalities and appropriate pharmacological therapy. The objective of kidney stone prevention programmes is to reduce recurrence, protect kidney function and help patients maintain long-term urinary health.